A novel method for diagnosing and managing prostate cancer has been developed.
Browsing: prostate cancer
A study led by researchers at The Institute of Cancer Research (London, UK) has uncovered numerous ways of targeting prostate cancer.
A study conducted out by Cancer Research UK has discovered that carrying out one-off PSA tests on asymptomatic men does not reduce prostate cancer deaths.
Three hospitals in the UK are trialing a ‘one-stop’ prostate cancer diagnosis service, which is expected to reduce the time taken for a diagnosis from approximately 6 weeks to just days.
Researchers have successfully utilized a novel metal detection technique for mapping and tracking breakaway cancerous cells.
Data recently released from Prostate Cancer UK demonstrates that prostate cancer has become the third most common cause of cancer death in the UK, overtaking breast cancer.
A prospective clinical study of the implications of IL-8 in the diagnosis, aggressiveness and prognosis of prostate cancer
In this research article from Future Science OA discover the implications of IL-8 in the diagnosis, aggressiveness and prognosis of prostate cancer.
Researchers have discovered that a shorter course of radiation using higher doses over fewer days may be a more effective approach for some men with intermediate-risk prostate cancer.
Prostate cancer screening and detection remain challenging issues, with changes in recommendations for prostate-specific antigen testing causing a significant change in approach. In this editorial discover the multiple roles and applications of prostate MRI.